1.75
price up icon9.37%   0.15
after-market Handel nachbörslich: 1.76 0.01 +0.57%
loading

Indaptus Therapeutics Inc Aktie (INDP) Neueste Nachrichten

pulisher
12:50 PM

Risk Off: Why is Indaptus Therapeutics Inc stock going up2026 Volume Leaders & High Yield Equity Trading Tips - baoquankhu1.vn

12:50 PM
pulisher
Apr 04, 2026

Indaptus Therapeutics Appoints Yu Ding as New Chief Financial Officer Effective April 2026 - Minichart

Apr 04, 2026
pulisher
Apr 04, 2026

Indaptus Therapeutics Names New CFO, Refreshes Board Oversight - The Globe and Mail

Apr 04, 2026
pulisher
Apr 03, 2026

Indaptus Therapeutics announces CFO transition and new board appointment - Investing.com

Apr 03, 2026
pulisher
Apr 03, 2026

INDP Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 03, 2026
pulisher
Apr 03, 2026

Indaptus appoints Yu Ding as CFO; Nir Sassi resigns - TradingView

Apr 03, 2026
pulisher
Apr 03, 2026

Indaptus Therapeutics (INDP) names new CFO and independent director - Stock Titan

Apr 03, 2026
pulisher
Apr 02, 2026

Indaptus Therapeutics Inc. (INDP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Apr 02, 2026
pulisher
Apr 02, 2026

Yun Yao converts preferred into 41.99M Indaptus (INDP) shares - Stock Titan

Apr 02, 2026
pulisher
Apr 02, 2026

SINO LION VENTURES (INDP) discloses 38.9M-share Indaptus stake via preferred conversion - Stock Titan

Apr 02, 2026
pulisher
Apr 02, 2026

Indaptus (INDP) CEO converts preferred stock into 11.25M common shares - Stock Titan

Apr 02, 2026
pulisher
Apr 02, 2026

Volatility Watch: Is Indaptus Therapeutics Inc stock undervalued right now2026 Catalysts & Advanced Swing Trade Entry Plans - baoquankhu1.vn

Apr 02, 2026
pulisher
Mar 31, 2026

Risk Hedge: Whats next for Indaptus Therapeutics Inc stock2026 Action & Free Weekly Watchlist of Top Performers - baoquankhu1.vn

Mar 31, 2026
pulisher
Mar 31, 2026

Revenue Check: Why is Indaptus Therapeutics Inc stock going upTrade Risk Assessment & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn

Mar 31, 2026
pulisher
Mar 30, 2026

New investor group takes large control stake in Indaptus Therapeutics (INDP) - Stock Titan

Mar 30, 2026
pulisher
Mar 30, 2026

Yun Yao Leads Investor Group, Secures CEO Change at Indaptus Therapeutics, Inc. with 37.8% Stake - TradingView

Mar 30, 2026
pulisher
Mar 30, 2026

Market Pulse: Why is Indaptus Therapeutics Inc stock going downWeekly Risk Summary & Safe Entry Zone Tips - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 30, 2026

Rate Cut: Should I hold or sell Indaptus Therapeutics Inc nowTrade Analysis Report & AI Powered Market Entry Ideas - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 26, 2026

Indaptus Therapeutics : 10-K 2025 Annual Report - marketscreener.com

Mar 26, 2026
pulisher
Mar 25, 2026

Insider Buyers Lose US$40k As Indaptus Therapeutics Sheds US$583k - simplywall.st

Mar 25, 2026
pulisher
Mar 25, 2026

Indaptus Therapeutics, Inc. Files Form 8-K Reporting Changes in Control – Key SEC Filing Details 3 - Minichart

Mar 25, 2026
pulisher
Mar 24, 2026

Indaptus Therapeutics (INDP) shifts control and names Junyi Dai CEO-Chair - Stock Titan

Mar 24, 2026
pulisher
Mar 24, 2026

Indaptus Therapeutics, Inc. Announces CEO Changes - MarketScreener

Mar 24, 2026
pulisher
Mar 24, 2026

Lazar cuts Indaptus (NASDAQ: INDP) preferred stake, resigns as co‑CEO but stays on board - Stock Titan

Mar 24, 2026
pulisher
Mar 24, 2026

Indaptus (INDP) director exits Series AAA stake, trims Series AA - Stock Titan

Mar 24, 2026
pulisher
Mar 22, 2026

Short Covering: Does Indaptus Therapeutics Inc have declining or rising EPS2026 Major Catalysts & Safe Entry Zone Identification - baoquankhu1.vn

Mar 22, 2026
pulisher
Mar 22, 2026

Market Outlook: Does Indaptus Therapeutics Inc have declining or rising EPSPortfolio Performance Report & Trade Opportunity Analysis Reports - baoquankhu1.vn

Mar 22, 2026
pulisher
Mar 18, 2026

Indaptus Therapeutics, Inc. 2025 Annual Report: Company Overview, Risks, Investment Transaction, and Regulatory Compliance - Minichart

Mar 18, 2026
pulisher
Mar 17, 2026

Indaptus Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener

Mar 17, 2026
pulisher
Mar 17, 2026

Lazar-backed Indaptus Therapeutics (NASDAQ: INDP) halts trials, eyes strategic deal - Stock Titan

Mar 17, 2026
pulisher
Mar 17, 2026

CEO Change: Will PANL stock hit new highs in YEAR2026 Sector Moves & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Mar 17, 2026
pulisher
Mar 16, 2026

Published on: 2026-03-17 18:45:40 - baoquankhu1.vn

Mar 16, 2026
pulisher
Mar 16, 2026

Indaptus Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt - MarketScreener

Mar 16, 2026
pulisher
Mar 14, 2026

INDPIndaptus Therapeutics Inc Latest Stock News & Market Updates - Stock Titan

Mar 14, 2026
pulisher
Mar 09, 2026

Indaptus Therapeutics (INDP) Stock Analysis Report | Financials & Insights - Benzinga Japan

Mar 09, 2026
pulisher
Mar 07, 2026

Why Indaptus Therapeutics Inc. stock remains on buy listsWeekly Stock Report & Safe Entry Momentum Tips - Naître et grandir

Mar 07, 2026
pulisher
Mar 06, 2026

Will Indaptus Therapeutics Inc. stock keep outperforming rivalsWeekly Trade Summary & Safe Entry Zone Identification - Naître et grandir

Mar 06, 2026
pulisher
Mar 06, 2026

Indaptus Therapeutics Inc expected to post a loss of $4.36 a shareEarnings Preview - TradingView

Mar 06, 2026
pulisher
Mar 05, 2026

Does Indaptus Therapeutics Inc. have declining or rising EPSPortfolio Profit Report & Daily Stock Momentum Reports - Mfd.ru

Mar 05, 2026
pulisher
Mar 05, 2026

Why Did INDP Stock Gain 12% Today? - Stocktwits

Mar 05, 2026
pulisher
Mar 05, 2026

Indaptus Therapeutics (INDP) Expected to Announce Quarterly Earnings on Thursday - Defense World

Mar 05, 2026
pulisher
Mar 03, 2026

CapEx per share of Indaptus Therapeutics, Inc. – NASDAQ:INDP - TradingView

Mar 03, 2026
pulisher
Mar 02, 2026

Lazar takes 98% control stake in Indaptus Therapeutics (INDP) via $6M deal - Stock Titan

Mar 02, 2026
pulisher
Feb 28, 2026

Indaptus Therapeutics, Inc. Announces $3.0 Million Registered Direct Offering and Concurrent Private Placement - marketscreener.com

Feb 28, 2026
pulisher
Feb 28, 2026

Indaptus Shareholders Approve Major Charter and Capital Changes - The Globe and Mail

Feb 28, 2026
pulisher
Feb 27, 2026

Indaptus Therapeutics shareholders approve preferred stock conversion and company charter amendments - Investing.com

Feb 27, 2026
pulisher
Feb 27, 2026

Indaptus (INDP) director Jerome Jabbour awarded options on 25,000 shares - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

Indaptus Therapeutics (NASDAQ: INDP) investors back control shift, share boost - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

Indaptus Therapeutics (INDP) director Jerome Jabbour files initial Form 3 - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

Rate Hike: Why is Indaptus Therapeutics Inc stock going up2025 Trading Recap & Weekly Stock Performance Updates - baoquankhu1.vn

Feb 27, 2026
pulisher
Feb 26, 2026

Indaptus Therapeutics (INDP) director discloses holding 25,000 common shares - Stock Titan

Feb 26, 2026
pulisher
Feb 25, 2026

INDP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Feb 25, 2026
pulisher
Feb 25, 2026

Volume Summary: Can Champion Homes Inc reach resistance levels soonGap Up & Verified Swing Trading Watchlist - baoquankhu1.vn

Feb 25, 2026
pulisher
Feb 24, 2026

INDP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 24, 2026
pulisher
Feb 15, 2026

Does Indaptus Therapeutics Inc. have a sustainable dividend2025 Technical Overview & Free Weekly Chart Analysis and Trade Guides - mfd.ru

Feb 15, 2026
pulisher
Feb 14, 2026

Can Indaptus Therapeutics Inc. stock reach $100 price target2025 Support & Resistance & Accurate Buy Signal Notifications - mfd.ru

Feb 14, 2026
pulisher
Feb 13, 2026

Indaptus Therapeutics Reprices Warrants to Bolster Shareholder Support - The Globe and Mail

Feb 13, 2026
pulisher
Feb 12, 2026

Indaptus Therapeutics Signs Multiple Material Agreements - TradingView

Feb 12, 2026
pulisher
Feb 12, 2026

What’s the analyst consensus on Indaptus Therapeutics Inc.Market Volume Summary & Risk Controlled Daily Trade Plans - mfd.ru

Feb 12, 2026
pulisher
Feb 11, 2026

Is Indaptus Therapeutics Inc. stock undervalued right nowJuly 2025 Review & Risk Managed Trade Strategies - mfd.ru

Feb 11, 2026
pulisher
Feb 11, 2026

How Indaptus Therapeutics Inc. stock benefits from strong dollarMarket Rally & Real-Time Volume Trigger Notifications - mfd.ru

Feb 11, 2026
pulisher
Feb 04, 2026

Published on: 2026-02-04 21:21:37 - baoquankhu1.vn

Feb 04, 2026
pulisher
Jan 29, 2026

INDP Price Today: Indaptus Therapeutics, Inc. Stock Price, Quote & Chart - mexc.co

Jan 29, 2026
$48.77
price down icon 0.87%
$27.88
price down icon 1.59%
$47.32
price down icon 2.57%
$91.28
price up icon 0.11%
ONC ONC
$302.49
price down icon 2.67%
$163.81
price up icon 0.85%
Kapitalisierung:     |  Volumen (24h):